 | • レポートコード：QYR2104Z6212 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、消退骨病のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医学療法、放射線療法）、用途別市場規模（病院、診療所、診断センター、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・消退骨病の市場動向 ・企業の競争状況、市場シェア ・消退骨病の種類別市場規模（医学療法、放射線療法） ・消退骨病の用途別市場規模（病院、診療所、診断センター、外来手術センター） ・消退骨病の北米市場規模2016-2027（アメリカ、カナダ） ・消退骨病のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・消退骨病のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・消退骨病の中南米市場規模2016-2027（メキシコ、ブラジル） ・消退骨病の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Varian Medical Systems、Elekta、BD、Merck、Sanofi、Roche、Novartis、Teleflex Incorporated、Vygon、Medtronic、Cook Medical、Smiths Medical、ATMOS MedizinTechnik） ・結論 |
Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteopenia and fracture.
The North American region dominates the global vanishing bone market due to the existing well-established healthcare system, increasing occurrences of rare diseases.
Market Analysis and Insights: Global Vanishing Bone Disease Market
The global Vanishing Bone Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vanishing Bone Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vanishing Bone Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vanishing Bone Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vanishing Bone Disease market.
Global Vanishing Bone Disease Scope and Market Size
Vanishing Bone Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vanishing Bone Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medicine Therapy
Radiation Therapy
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Varian Medical Systems
Elekta
BD
Merck
Sanofi
Roche
Novartis
Teleflex Incorporated
Vygon
Merck
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vanishing Bone Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicine Therapy
1.2.3 Radiation Therapy
1.3 Market by Application
1.3.1 Global Vanishing Bone Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vanishing Bone Disease Market Perspective (2016-2027)
2.2 Vanishing Bone Disease Growth Trends by Regions
2.2.1 Vanishing Bone Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vanishing Bone Disease Historic Market Share by Regions (2016-2021)
2.2.3 Vanishing Bone Disease Forecasted Market Size by Regions (2022-2027)
2.3 Vanishing Bone Disease Industry Dynamic
2.3.1 Vanishing Bone Disease Market Trends
2.3.2 Vanishing Bone Disease Market Drivers
2.3.3 Vanishing Bone Disease Market Challenges
2.3.4 Vanishing Bone Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vanishing Bone Disease Players by Revenue
3.1.1 Global Top Vanishing Bone Disease Players by Revenue (2016-2021)
3.1.2 Global Vanishing Bone Disease Revenue Market Share by Players (2016-2021)
3.2 Global Vanishing Bone Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vanishing Bone Disease Revenue
3.4 Global Vanishing Bone Disease Market Concentration Ratio
3.4.1 Global Vanishing Bone Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vanishing Bone Disease Revenue in 2020
3.5 Vanishing Bone Disease Key Players Head office and Area Served
3.6 Key Players Vanishing Bone Disease Product Solution and Service
3.7 Date of Enter into Vanishing Bone Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vanishing Bone Disease Breakdown Data by Type
4.1 Global Vanishing Bone Disease Historic Market Size by Type (2016-2021)
4.2 Global Vanishing Bone Disease Forecasted Market Size by Type (2022-2027)
5 Vanishing Bone Disease Breakdown Data by Application
5.1 Global Vanishing Bone Disease Historic Market Size by Application (2016-2021)
5.2 Global Vanishing Bone Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Vanishing Bone Disease Market Size (2016-2027)
6.2 North America Vanishing Bone Disease Market Size by Type
6.2.1 North America Vanishing Bone Disease Market Size by Type (2016-2021)
6.2.2 North America Vanishing Bone Disease Market Size by Type (2022-2027)
6.2.3 North America Vanishing Bone Disease Market Size by Type (2016-2027)
6.3 North America Vanishing Bone Disease Market Size by Application
6.3.1 North America Vanishing Bone Disease Market Size by Application (2016-2021)
6.3.2 North America Vanishing Bone Disease Market Size by Application (2022-2027)
6.3.3 North America Vanishing Bone Disease Market Size by Application (2016-2027)
6.4 North America Vanishing Bone Disease Market Size by Country
6.4.1 North America Vanishing Bone Disease Market Size by Country (2016-2021)
6.4.2 North America Vanishing Bone Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Vanishing Bone Disease Market Size (2016-2027)
7.2 Europe Vanishing Bone Disease Market Size by Type
7.2.1 Europe Vanishing Bone Disease Market Size by Type (2016-2021)
7.2.2 Europe Vanishing Bone Disease Market Size by Type (2022-2027)
7.2.3 Europe Vanishing Bone Disease Market Size by Type (2016-2027)
7.3 Europe Vanishing Bone Disease Market Size by Application
7.3.1 Europe Vanishing Bone Disease Market Size by Application (2016-2021)
7.3.2 Europe Vanishing Bone Disease Market Size by Application (2022-2027)
7.3.3 Europe Vanishing Bone Disease Market Size by Application (2016-2027)
7.4 Europe Vanishing Bone Disease Market Size by Country
7.4.1 Europe Vanishing Bone Disease Market Size by Country (2016-2021)
7.4.2 Europe Vanishing Bone Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Vanishing Bone Disease Market Size (2016-2027)
8.2 Asia-Pacific Vanishing Bone Disease Market Size by Type
8.2.1 Asia-Pacific Vanishing Bone Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vanishing Bone Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vanishing Bone Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Vanishing Bone Disease Market Size by Application
8.3.1 Asia-Pacific Vanishing Bone Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vanishing Bone Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vanishing Bone Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Vanishing Bone Disease Market Size by Region
8.4.1 Asia-Pacific Vanishing Bone Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vanishing Bone Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Vanishing Bone Disease Market Size (2016-2027)
9.2 Latin America Vanishing Bone Disease Market Size by Type
9.2.1 Latin America Vanishing Bone Disease Market Size by Type (2016-2021)
9.2.2 Latin America Vanishing Bone Disease Market Size by Type (2022-2027)
9.2.3 Latin America Vanishing Bone Disease Market Size by Type (2016-2027)
9.3 Latin America Vanishing Bone Disease Market Size by Application
9.3.1 Latin America Vanishing Bone Disease Market Size by Application (2016-2021)
9.3.2 Latin America Vanishing Bone Disease Market Size by Application (2022-2027)
9.3.3 Latin America Vanishing Bone Disease Market Size by Application (2016-2027)
9.4 Latin America Vanishing Bone Disease Market Size by Country
9.4.1 Latin America Vanishing Bone Disease Market Size by Country (2016-2021)
9.4.2 Latin America Vanishing Bone Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vanishing Bone Disease Market Size (2016-2027)
10.2 Middle East & Africa Vanishing Bone Disease Market Size by Type
10.2.1 Middle East & Africa Vanishing Bone Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vanishing Bone Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vanishing Bone Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Vanishing Bone Disease Market Size by Application
10.3.1 Middle East & Africa Vanishing Bone Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vanishing Bone Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vanishing Bone Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Vanishing Bone Disease Market Size by Country
10.4.1 Middle East & Africa Vanishing Bone Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vanishing Bone Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Varian Medical Systems
11.1.1 Varian Medical Systems Company Details
11.1.2 Varian Medical Systems Business Overview
11.1.3 Varian Medical Systems Vanishing Bone Disease Introduction
11.1.4 Varian Medical Systems Revenue in Vanishing Bone Disease Business (2016-2021)
11.1.5 Varian Medical Systems Recent Development
11.2 Elekta
11.2.1 Elekta Company Details
11.2.2 Elekta Business Overview
11.2.3 Elekta Vanishing Bone Disease Introduction
11.2.4 Elekta Revenue in Vanishing Bone Disease Business (2016-2021)
11.2.5 Elekta Recent Development
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Vanishing Bone Disease Introduction
11.3.4 BD Revenue in Vanishing Bone Disease Business (2016-2021)
11.3.5 BD Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Vanishing Bone Disease Introduction
11.4.4 Merck Revenue in Vanishing Bone Disease Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Vanishing Bone Disease Introduction
11.5.4 Sanofi Revenue in Vanishing Bone Disease Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Vanishing Bone Disease Introduction
11.6.4 Roche Revenue in Vanishing Bone Disease Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Vanishing Bone Disease Introduction
11.7.4 Novartis Revenue in Vanishing Bone Disease Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Teleflex Incorporated
11.8.1 Teleflex Incorporated Company Details
11.8.2 Teleflex Incorporated Business Overview
11.8.3 Teleflex Incorporated Vanishing Bone Disease Introduction
11.8.4 Teleflex Incorporated Revenue in Vanishing Bone Disease Business (2016-2021)
11.8.5 Teleflex Incorporated Recent Development
11.9 Vygon
11.9.1 Vygon Company Details
11.9.2 Vygon Business Overview
11.9.3 Vygon Vanishing Bone Disease Introduction
11.9.4 Vygon Revenue in Vanishing Bone Disease Business (2016-2021)
11.9.5 Vygon Recent Development
11.10 Medtronic
11.10.1 Medtronic Company Details
11.10.2 Medtronic Business Overview
11.10.3 Medtronic Vanishing Bone Disease Introduction
11.10.4 Medtronic Revenue in Vanishing Bone Disease Business (2016-2021)
11.10.5 Medtronic Recent Development
11.11 Cook Medical
11.11.1 Cook Medical Company Details
11.11.2 Cook Medical Business Overview
11.11.3 Cook Medical Vanishing Bone Disease Introduction
11.11.4 Cook Medical Revenue in Vanishing Bone Disease Business (2016-2021)
11.11.5 Cook Medical Recent Development
11.12 Smiths Medical
11.12.1 Smiths Medical Company Details
11.12.2 Smiths Medical Business Overview
11.12.3 Smiths Medical Vanishing Bone Disease Introduction
11.12.4 Smiths Medical Revenue in Vanishing Bone Disease Business (2016-2021)
11.12.5 Smiths Medical Recent Development
11.13 ATMOS MedizinTechnik
11.13.1 ATMOS MedizinTechnik Company Details
11.13.2 ATMOS MedizinTechnik Business Overview
11.13.3 ATMOS MedizinTechnik Vanishing Bone Disease Introduction
11.13.4 ATMOS MedizinTechnik Revenue in Vanishing Bone Disease Business (2016-2021)
11.13.5 ATMOS MedizinTechnik Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Vanishing Bone Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicine Therapy
Table 3. Key Players of Radiation Therapy
Table 4. Global Vanishing Bone Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Vanishing Bone Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Vanishing Bone Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Vanishing Bone Disease Market Share by Regions (2016-2021)
Table 8. Global Vanishing Bone Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Vanishing Bone Disease Market Share by Regions (2022-2027)
Table 10. Vanishing Bone Disease Market Trends
Table 11. Vanishing Bone Disease Market Drivers
Table 12. Vanishing Bone Disease Market Challenges
Table 13. Vanishing Bone Disease Market Restraints
Table 14. Global Vanishing Bone Disease Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Vanishing Bone Disease Market Share by Players (2016-2021)
Table 16. Global Top Vanishing Bone Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vanishing Bone Disease as of 2020)
Table 17. Ranking of Global Top Vanishing Bone Disease Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Vanishing Bone Disease Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Vanishing Bone Disease Product Solution and Service
Table 21. Date of Enter into Vanishing Bone Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vanishing Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Vanishing Bone Disease Revenue Market Share by Type (2016-2021)
Table 25. Global Vanishing Bone Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Vanishing Bone Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Vanishing Bone Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Vanishing Bone Disease Revenue Market Share by Application (2016-2021)
Table 29. Global Vanishing Bone Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Vanishing Bone Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Vanishing Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Vanishing Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Vanishing Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Vanishing Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Vanishing Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Vanishing Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Vanishing Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Vanishing Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Vanishing Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Vanishing Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Vanishing Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Vanishing Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Vanishing Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Vanishing Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Vanishing Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Vanishing Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Vanishing Bone Disease Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Vanishing Bone Disease Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Vanishing Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Vanishing Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Vanishing Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Vanishing Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Vanishing Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Vanishing Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Vanishing Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Vanishing Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Vanishing Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Vanishing Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Vanishing Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Vanishing Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 61. Varian Medical Systems Company Details
Table 62. Varian Medical Systems Business Overview
Table 63. Varian Medical Systems Vanishing Bone Disease Product
Table 64. Varian Medical Systems Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 65. Varian Medical Systems Recent Development
Table 66. Elekta Company Details
Table 67. Elekta Business Overview
Table 68. Elekta Vanishing Bone Disease Product
Table 69. Elekta Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 70. Elekta Recent Development
Table 71. BD Company Details
Table 72. BD Business Overview
Table 73. BD Vanishing Bone Disease Product
Table 74. BD Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 75. BD Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Vanishing Bone Disease Product
Table 79. Merck Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Vanishing Bone Disease Product
Table 84. Sanofi Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Vanishing Bone Disease Product
Table 89. Roche Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Vanishing Bone Disease Product
Table 94. Novartis Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. Teleflex Incorporated Company Details
Table 97. Teleflex Incorporated Business Overview
Table 98. Teleflex Incorporated Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 99. Teleflex Incorporated Recent Development
Table 100. Vygon Company Details
Table 101. Vygon Business Overview
Table 102. Vygon Vanishing Bone Disease Product
Table 103. Vygon Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 104. Vygon Recent Development
Table 105. Medtronic Company Details
Table 106. Medtronic Business Overview
Table 107. Medtronic Vanishing Bone Disease Product
Table 108. Medtronic Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 109. Medtronic Recent Development
Table 110. Cook Medical Company Details
Table 111. Cook Medical Business Overview
Table 112. Cook Medical Vanishing Bone Disease Product
Table 113. Cook Medical Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 114. Cook Medical Recent Development
Table 115. Smiths Medical Company Details
Table 116. Smiths Medical Business Overview
Table 117. Smiths Medical Vanishing Bone Disease Product
Table 118. Smiths Medical Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 119. Smiths Medical Recent Development
Table 120. ATMOS MedizinTechnik Company Details
Table 121. ATMOS MedizinTechnik Business Overview
Table 122. ATMOS MedizinTechnik Vanishing Bone Disease Product
Table 123. ATMOS MedizinTechnik Revenue in Vanishing Bone Disease Business (2016-2021) & (US$ Million)
Table 124. ATMOS MedizinTechnik Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vanishing Bone Disease Market Share by Type: 2020 VS 2027
Figure 2. Medicine Therapy Features
Figure 3. Radiation Therapy Features
Figure 4. Global Vanishing Bone Disease Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Vanishing Bone Disease Report Years Considered
Figure 10. Global Vanishing Bone Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Vanishing Bone Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Vanishing Bone Disease Market Share by Regions: 2020 VS 2027
Figure 13. Global Vanishing Bone Disease Market Share by Regions (2022-2027)
Figure 14. Global Vanishing Bone Disease Market Share by Players in 2020
Figure 15. Global Top Vanishing Bone Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vanishing Bone Disease as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Vanishing Bone Disease Revenue in 2020
Figure 17. Global Vanishing Bone Disease Revenue Market Share by Type (2016-2021)
Figure 18. Global Vanishing Bone Disease Revenue Market Share by Type (2022-2027)
Figure 19. North America Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Vanishing Bone Disease Market Share by Type (2016-2027)
Figure 21. North America Vanishing Bone Disease Market Share by Application (2016-2027)
Figure 22. North America Vanishing Bone Disease Market Share by Country (2016-2027)
Figure 23. United States Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Vanishing Bone Disease Market Share by Type (2016-2027)
Figure 27. Europe Vanishing Bone Disease Market Share by Application (2016-2027)
Figure 28. Europe Vanishing Bone Disease Market Share by Country (2016-2027)
Figure 29. Germany Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Vanishing Bone Disease Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Vanishing Bone Disease Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Vanishing Bone Disease Market Share by Region (2016-2027)
Figure 39. China Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Vanishing Bone Disease Market Share by Type (2016-2027)
Figure 47. Latin America Vanishing Bone Disease Market Share by Application (2016-2027)
Figure 48. Latin America Vanishing Bone Disease Market Share by Country (2016-2027)
Figure 49. Mexico Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Vanishing Bone Disease Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Vanishing Bone Disease Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Vanishing Bone Disease Market Share by Country (2016-2027)
Figure 55. Turkey Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Vanishing Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Varian Medical Systems Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 59. Elekta Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 60. BD Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 65. Teleflex Incorporated Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 66. Vygon Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 67. Medtronic Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 68. Cook Medical Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 69. Smiths Medical Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 70. ATMOS MedizinTechnik Revenue Growth Rate in Vanishing Bone Disease Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の転移性骨疾患治療市場規模・現状・予測（2021年-2027年） Metastatic bone disease treatments are treatment options of MBD which is a kind of cancer that begins in an organ, such as the lungs, breast, or prostate, and then spreads to bone. Market Analysis and Insights: Global Metastatic Bone Disease Treatment Market The global Metastatic Bone Disease Treatm…- 世界の骨転移治療市場規模・現状・予測（2021年-2027年） Bone metastasis is the third most common condition in metastatic cancers and occurs in 60-65% of patients with metastatic cancers. The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic…
- 世界の骨転移治療市場規模・現状・予測（2021年-2027年） Bone metastasis is the third most common condition in metastatic cancers and occurs in 60-65% of patients with metastatic cancers. The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic…
- 世界の骨・ミネラル診断検査市場規模・現状・予測（2021年-2027年） Bone and mineral metabolism disorder is a collective term used to describe various conditions that make bones weak. Bone mineral metabolism maintains sufficient concentration of inorganic ions in blood serum. Progressive chronic kidney disease, especially end-stage renal disease (ESRD), is responsib…
- 世界の歯科用骨代替品・生体材料市場規模・現状・予測（2021年-2027年） Dental bone grafts substitutes and biomaterials are regenerative products which are used as a filler support to facilitate dental bone formation and accelerate wound healing. These dental grafts are bioresorbable or biocompatible with no antigen-antibody reaction. These dental bone substitutes assis…